Movie Industry

'Dune 3': Jason Momoa Returns → Anya Taylor-Joy Joins the Cast… To Cap Off the Finale

The Movie 'Dune: Part 3' World Premiere in South Korea on the 16th of Next Month

Choi Hee-jae
2026-11-19 10:38:54
[Edaily Reporter Choi Hee-jae ] "Dune: Part 3," which depicts the fate of Paul, who has seized absolute power, and those who stand against him, brings the series to a close.
Poster for the movie “Dune: Part 3” (Photo courtesy of Warner Bros. Korea)

The movie “Dune: Part 3” is an action blockbuster depicting “Paul” (Timothée Chalamet), who inherits absolute power and becomes a tyrant, and “Chani” (Zendaya), the desert warrior who stands against him, as well as the massive war and fateful confrontation they face.

The “Dune” series, which has captivated audiences worldwide, brings its saga to a close with the intertwined fates of “Paul”—now the Emperor—and those around him. Three key figures connected to “Paul” are set to take center stage: a warrior who met his end protecting the family heir; a princess who became empress through a political marriage; and a younger sibling whose fate has been intertwined with the family’s since before birth.

Jason Momoa, who played “Duncan,” a loyal servant of the Atreides family in *Dune*, returns as the clone “Hate.” When the family was destroyed by the Harkonnen attack, “Duncan” met a heroic end while helping “Paul” and “Lady Jessica” (Rebecca Ferguson) escape.

In this installment, he is resurrected as a clone named “Hate.” Appearing before Emperor “Paul,” he retains not only Duncan’s exact appearance but also his combat abilities. Attention is focused on how the arrival of “Hate”—who bears the face of his former mentor—will affect the relationship between the two characters.

In *Dune: Part 2*, “Irulan” (Florence Pugh), who witnessed the downfall of her father, the Emperor (Christopher Walken), becomes Empress through a political marriage to “Paul,” who seeks to seize power—though she has already lost her actual authority. Nineteen years later, as “Paul”—whom she once respected—transforms into a ruthless tyrant, “Irulan” watches him with fear that even her own life may be in danger.

As forces seeking to topple “Paul” begin to rally, “Irulan”—the daughter of the former imperial family and wife of the new emperor—finds herself once again at the center of a power struggle. It will be intriguing to see how Florence Pugh portrays the complex inner world of “Irulan,” who, despite ascending to the throne as empress, cannot rest easy.

In *Dune: Part 2*, “Alia” possesses extraordinary abilities from the moment she was conceived, thanks to the “Water of Life” consumed by “Lady Jessica.” Anya Taylor-Joy, who made a brief appearance in the previous film as a grown-up “Alia” in “Paul’s” vision, takes center stage in this installment as “Alia,” the younger sister with the ability to foresee the future.

Deeply intertwined with the fate of the Atreides family and her brother “Paul” even before her birth, she is set to add tension to the film with her extraordinary foresight and mysterious aura, showcasing a truly unique presence.

“Dune: Part 3” will have its world premiere in South Korean theaters on the 16th of next month.

Economy

Corporation

IT·Science

Economy

Genexine, Inc.: How Long Can It Keep Selling Assets to Stay Afloat?…Debt Alone Totals 105.4 Billion Won

Genexine, Inc.(095700)is securing the cash needed for research and development and operations by disposing of its financial assets, but its debt and interest burden remain significant. Genexine, In…
2026-11-19 10:32:02

Corporation

After Enhancing the Flavor and Adding Protein… TakeFit Sees Sales Jump 48%

NamyangDairyProducts(003920)’s protein brand “TakeFit” saw its cumulative sales for the third quarter of this year increase by 48.3% compared to the same period last year. Analysts attribute this grow…
2026-11-19 09:14:40

IT·Science

Park Beom-chan, CEO of Y-Bio: “Big Pharma’s Interest in SITC Results on the Rise… Aiming to Export AR170 Technology Next Year”

“Through a study on patient-derived tissue recently presented at the Society for Immunotherapy of Cancer (SITC) in the U.S., we have confirmed the potential for our next-generation immuno-oncology dru…
2026-11-19 11:01:02